Paper41550348
Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility.
Salazar-Garcés LF and 4 others. Front Digit Health, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility. Papers, record 41550348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41550348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32419014 | Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China. | Jpn J Clin Oncol | 2020 | https://conductscience.org/library/papers/32419014 | PubMed |
| 2 | 39650663 | Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/39650663 | PubMed |
| 3 | 30849111 | A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis. | PLoS One | 2019 | https://conductscience.org/library/papers/30849111 | PubMed |
| 4 | 39628476 | Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment. | Front Immunol | 2024 | https://conductscience.org/library/papers/39628476 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 40112233 | Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations. | JCO Clin Cancer Inform | 2025 | https://conductscience.org/library/papers/40112233 | PubMed |
| 7 | 32121160 | Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32121160 | PubMed |
| 8 | 27254875 | Discovery and Clinical Decision Support for Personalized Healthcare. | IEEE J Biomed Health Inform | 2017 | https://conductscience.org/library/papers/27254875 | PubMed |
| 9 | 39749373 | Evaluation of machine learning algorithms and computational structural validation of CYP2D6 in predicting the therapeutic response to tamoxifen in breast cancer. | Eur Rev Med Pharmacol Sci | 2024 | https://conductscience.org/library/papers/39749373 | PubMed |
| 10 | 39099625 | Consistency of CSCO AI with Multidisciplinary Clinical Decision-Making Teams in Breast Cancer: A Retrospective Study. | Breast Cancer (Dove Med Press) | 2024 | https://conductscience.org/library/papers/39099625 | PubMed |
| 11 | 31419181 | Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise. | JCO Clin Cancer Inform | 2019 | https://conductscience.org/library/papers/31419181 | PubMed |
| 12 | 37530243 | Analysis of Watson for oncology and clinicians' treatment recommendations for patients with breast cancer in Korea: A single center experience. | Indian J Cancer | 2023 | https://conductscience.org/library/papers/37530243 | PubMed |
| 13 | 40308601 | Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40308601 | PubMed |
| 14 | 39669975 | Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39669975 | PubMed |
| 15 | 38756785 | Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature. | Front Immunol | 2024 | https://conductscience.org/library/papers/38756785 | PubMed |
| 16 | 32992569 | Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32992569 | PubMed |
| 17 | 28263386 | Artificial intelligence platform for oncology could assist in treatment decisions. | Cancer | 2017 | https://conductscience.org/library/papers/28263386 | PubMed |
| 18 | 29324970 | Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29324970 | PubMed |
| 19 | 32970484 | Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer. | JCO Clin Cancer Inform | 2020 | https://conductscience.org/library/papers/32970484 | PubMed |
| 20 | 38504988 | Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making. | Front Immunol | 2024 | https://conductscience.org/library/papers/38504988 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42752875 | Sustainable artificial intelligence in global health: balancing promise, equity, and environmental realities in low- and middle-income countries. | J Am Med Inform Assoc | 2026 | https://conductscience.org/library/papers/42752875 | PubMed |
| 42589412 | Artificial Intelligence and Genomic Data Analysis: New Frontiers in Precision Medicine. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589412 | PubMed |
| 42072806 | Advances in Breast Cancer Diagnostics: From Screening to Precision Medicine. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42072806 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41550348
GET https://conductscience.org/api/papers/v1/41550348/authors